Structure

Physi-Chem Properties

Molecular Weight:  212.07
Volume:  206.365
LogP:  -0.16
LogD:  0.054
LogS:  -1.471
# Rotatable Bonds:  4
TPSA:  86.99
# H-Bond Aceptor:  5
# H-Bond Donor:  3
# Rings:  1
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.608
Synthetic Accessibility Score:  2.598
Fsp3:  0.3
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.911
MDCK Permeability:  5.9481593780219555e-05
Pgp-inhibitor:  0.001
Pgp-substrate:  0.006
Human Intestinal Absorption (HIA):  0.108
20% Bioavailability (F20%):  0.043
30% Bioavailability (F30%):  0.892

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.88
Plasma Protein Binding (PPB):  55.48407745361328%
Volume Distribution (VD):  0.701
Pgp-substrate:  42.37657928466797%

ADMET: Metabolism

CYP1A2-inhibitor:  0.115
CYP1A2-substrate:  0.289
CYP2C19-inhibitor:  0.024
CYP2C19-substrate:  0.2
CYP2C9-inhibitor:  0.008
CYP2C9-substrate:  0.561
CYP2D6-inhibitor:  0.011
CYP2D6-substrate:  0.33
CYP3A4-inhibitor:  0.021
CYP3A4-substrate:  0.139

ADMET: Excretion

Clearance (CL):  4.857
Half-life (T1/2):  0.89

ADMET: Toxicity

hERG Blockers:  0.046
Human Hepatotoxicity (H-HT):  0.035
Drug-inuced Liver Injury (DILI):  0.441
AMES Toxicity:  0.269
Rat Oral Acute Toxicity:  0.025
Maximum Recommended Daily Dose:  0.006
Skin Sensitization:  0.086
Carcinogencity:  0.032
Eye Corrosion:  0.003
Eye Irritation:  0.169
Respiratory Toxicity:  0.035

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC325625

Natural Product ID:  NPC325625
Common Name*:   2,3-Dihydroxy-1-(4-Hydroxy-3-Methoxyphenyl)Propan-1-One
IUPAC Name:   2,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)propan-1-one
Synonyms:  
Standard InCHIKey:  UTXNRISXYKZJTH-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C10H12O5/c1-15-9-4-6(2-3-7(9)12)10(14)8(13)5-11/h2-4,8,11-13H,5H2,1H3
SMILES:  OCC(C(=O)c1ccc(c(c1)OC)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL590536
PubChem CID:   15765124
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0001831] Carbonyl compounds
          • [CHEMONTID:0000118] Ketones
            • [CHEMONTID:0003670] Aryl ketones
              • [CHEMONTID:0004296] Phenylketones
                • [CHEMONTID:0004298] Alkyl-phenylketones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO21361 Anastatica hierochuntica Species Brassicaceae Eukaryota n.a. n.a. n.a. PMID[12643908]
NPO17691 Santalum album Species Santalaceae Eukaryota n.a. n.a. n.a. PMID[15974602]
NPO21361 Anastatica hierochuntica Species Brassicaceae Eukaryota n.a. n.a. n.a. PMID[20189399]
NPO17691 Santalum album Species Santalaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO17691 Santalum album Species Santalaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO17691 Santalum album Species Santalaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO17691 Santalum album Species Santalaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO21361 Anastatica hierochuntica Species Brassicaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO17691 Santalum album Species Santalaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT43 Individual Protein Tyrosinase Agaricus bisporus Inhibition < 10.4 % PMID[521178]
NPT346 Individual Protein Transient receptor potential cation channel subfamily A member 1 Homo sapiens Activity = 63.0 % PMID[521179]
NPT2 Others Unspecified Inhibition = 16.5 % PMID[521178]
NPT2 Others Unspecified Inhibition = 18.1 % PMID[521178]
NPT2 Others Unspecified Inhibition = 24.0 % PMID[521178]
NPT2 Others Unspecified Inhibition = 25.8 % PMID[521178]
NPT27 Others Unspecified Inhibition < 8.8 % PMID[521178]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC325625 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9771 High Similarity NPC139519
0.9542 High Similarity NPC50763
0.9338 High Similarity NPC4796
0.9209 High Similarity NPC46161
0.9209 High Similarity NPC239608
0.916 High Similarity NPC16651
0.916 High Similarity NPC32163
0.9044 High Similarity NPC208760
0.9037 High Similarity NPC283823
0.9037 High Similarity NPC307006
0.9037 High Similarity NPC129889
0.9037 High Similarity NPC159418
0.8993 High Similarity NPC50823
0.8963 High Similarity NPC111888
0.8921 High Similarity NPC474784
0.8921 High Similarity NPC322021
0.8889 High Similarity NPC474903
0.8873 High Similarity NPC469683
0.8872 High Similarity NPC203719
0.8872 High Similarity NPC117237
0.8865 High Similarity NPC299154
0.8815 High Similarity NPC195292
0.8815 High Similarity NPC66905
0.8815 High Similarity NPC285776
0.8815 High Similarity NPC142985
0.8811 High Similarity NPC287495
0.8811 High Similarity NPC9370
0.8803 High Similarity NPC469615
0.8768 High Similarity NPC274613
0.875 High Similarity NPC226987
0.875 High Similarity NPC143903
0.875 High Similarity NPC469480
0.8741 High Similarity NPC142165
0.8732 High Similarity NPC312256
0.8731 High Similarity NPC20404
0.8731 High Similarity NPC281020
0.8731 High Similarity NPC293641
0.8731 High Similarity NPC12022
0.8731 High Similarity NPC20287
0.8716 High Similarity NPC25127
0.8699 High Similarity NPC264550
0.8699 High Similarity NPC40290
0.8699 High Similarity NPC200060
0.8699 High Similarity NPC139293
0.8699 High Similarity NPC69430
0.8699 High Similarity NPC195763
0.8699 High Similarity NPC205054
0.8699 High Similarity NPC142876
0.8699 High Similarity NPC264289
0.8699 High Similarity NPC333691
0.8696 High Similarity NPC237330
0.869 High Similarity NPC125449
0.869 High Similarity NPC98009
0.869 High Similarity NPC188074
0.869 High Similarity NPC472969
0.8681 High Similarity NPC30890
0.8676 High Similarity NPC298268
0.8675 High Similarity NPC472962
0.8675 High Similarity NPC472961
0.8671 High Similarity NPC287722
0.8671 High Similarity NPC254659
0.8671 High Similarity NPC473090
0.8667 High Similarity NPC278308
0.8667 High Similarity NPC52530
0.8662 High Similarity NPC84273
0.8662 High Similarity NPC110419
0.8649 High Similarity NPC327225
0.8643 High Similarity NPC112068
0.8643 High Similarity NPC110899
0.8643 High Similarity NPC25305
0.8643 High Similarity NPC95679
0.8643 High Similarity NPC125417
0.8636 High Similarity NPC114298
0.863 High Similarity NPC183655
0.863 High Similarity NPC139364
0.863 High Similarity NPC98809
0.863 High Similarity NPC80710
0.863 High Similarity NPC203747
0.863 High Similarity NPC254702
0.863 High Similarity NPC287395
0.863 High Similarity NPC194653
0.863 High Similarity NPC476394
0.8626 High Similarity NPC225245
0.8618 High Similarity NPC308992
0.8611 High Similarity NPC207732
0.8609 High Similarity NPC477410
0.8603 High Similarity NPC261759
0.8603 High Similarity NPC226855
0.8601 High Similarity NPC301178
0.8601 High Similarity NPC284556
0.86 High Similarity NPC326037
0.86 High Similarity NPC13858
0.86 High Similarity NPC320825
0.8593 High Similarity NPC158654
0.8592 High Similarity NPC326065
0.8591 High Similarity NPC287504
0.8591 High Similarity NPC246328
0.8591 High Similarity NPC325028
0.8591 High Similarity NPC27532
0.8591 High Similarity NPC256346
0.8582 High Similarity NPC284409
0.8581 High Similarity NPC151425
0.8581 High Similarity NPC31363
0.8571 High Similarity NPC242372
0.8571 High Similarity NPC4181
0.8571 High Similarity NPC164778
0.8571 High Similarity NPC324929
0.8571 High Similarity NPC92722
0.8571 High Similarity NPC257976
0.8571 High Similarity NPC102003
0.8562 High Similarity NPC294972
0.8553 High Similarity NPC263449
0.8552 High Similarity NPC98356
0.8542 High Similarity NPC50954
0.8542 High Similarity NPC119663
0.8542 High Similarity NPC471417
0.854 High Similarity NPC137427
0.854 High Similarity NPC311419
0.854 High Similarity NPC123196
0.854 High Similarity NPC65935
0.854 High Similarity NPC215941
0.854 High Similarity NPC172673
0.854 High Similarity NPC244246
0.854 High Similarity NPC275724
0.854 High Similarity NPC319282
0.8523 High Similarity NPC269451
0.8523 High Similarity NPC216769
0.8523 High Similarity NPC246162
0.8523 High Similarity NPC100971
0.8523 High Similarity NPC209487
0.8523 High Similarity NPC477231
0.8523 High Similarity NPC131266
0.8523 High Similarity NPC35763
0.8523 High Similarity NPC245382
0.8523 High Similarity NPC61506
0.8523 High Similarity NPC240476
0.8523 High Similarity NPC55205
0.8523 High Similarity NPC181209
0.8523 High Similarity NPC9743
0.8523 High Similarity NPC121522
0.8523 High Similarity NPC100263
0.8523 High Similarity NPC291802
0.8523 High Similarity NPC257648
0.8523 High Similarity NPC36835
0.8523 High Similarity NPC260491
0.8523 High Similarity NPC304954
0.8521 High Similarity NPC288452
0.8521 High Similarity NPC289690
0.8519 High Similarity NPC154275
0.8514 High Similarity NPC260582
0.8514 High Similarity NPC29231
0.8514 High Similarity NPC472279
0.8507 High Similarity NPC312404
0.8507 High Similarity NPC273686
0.8503 High Similarity NPC131451
0.8503 High Similarity NPC15329
0.85 High Similarity NPC470990
0.8493 Intermediate Similarity NPC32058
0.8493 Intermediate Similarity NPC165389
0.8493 Intermediate Similarity NPC12377
0.8493 Intermediate Similarity NPC85734
0.8489 Intermediate Similarity NPC327410
0.8487 Intermediate Similarity NPC55738
0.8483 Intermediate Similarity NPC242893
0.8483 Intermediate Similarity NPC275278
0.8483 Intermediate Similarity NPC38065
0.8477 Intermediate Similarity NPC265511
0.8477 Intermediate Similarity NPC250922
0.8477 Intermediate Similarity NPC474638
0.8477 Intermediate Similarity NPC201837
0.8473 Intermediate Similarity NPC299406
0.8467 Intermediate Similarity NPC124714
0.8456 Intermediate Similarity NPC45291
0.8456 Intermediate Similarity NPC473201
0.8456 Intermediate Similarity NPC19980
0.8456 Intermediate Similarity NPC200740
0.8456 Intermediate Similarity NPC54394
0.8456 Intermediate Similarity NPC302783
0.8456 Intermediate Similarity NPC276466
0.8456 Intermediate Similarity NPC252933
0.8456 Intermediate Similarity NPC256406
0.8456 Intermediate Similarity NPC5018
0.8456 Intermediate Similarity NPC75695
0.8456 Intermediate Similarity NPC151167
0.8456 Intermediate Similarity NPC123228
0.8456 Intermediate Similarity NPC123722
0.8456 Intermediate Similarity NPC125062
0.844 Intermediate Similarity NPC475111
0.8435 Intermediate Similarity NPC61871
0.8435 Intermediate Similarity NPC30647
0.8435 Intermediate Similarity NPC168803
0.8435 Intermediate Similarity NPC119660
0.8435 Intermediate Similarity NPC55557
0.8435 Intermediate Similarity NPC93034
0.8433 Intermediate Similarity NPC244876
0.8433 Intermediate Similarity NPC474691
0.8431 Intermediate Similarity NPC287328
0.8431 Intermediate Similarity NPC282009
0.8429 Intermediate Similarity NPC155098
0.8429 Intermediate Similarity NPC471110

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC325625 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8872 High Similarity NPD9494 Approved
0.86 High Similarity NPD3882 Suspended
0.84 Intermediate Similarity NPD1934 Approved
0.8243 Intermediate Similarity NPD1512 Approved
0.8227 Intermediate Similarity NPD230 Phase 1
0.8224 Intermediate Similarity NPD2801 Approved
0.8217 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8217 Intermediate Similarity NPD6166 Phase 2
0.8217 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8108 Intermediate Similarity NPD1511 Approved
0.8105 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8029 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD3818 Discontinued
0.7935 Intermediate Similarity NPD3817 Phase 2
0.7931 Intermediate Similarity NPD1510 Phase 2
0.7931 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7905 Intermediate Similarity NPD4628 Phase 3
0.7902 Intermediate Similarity NPD1240 Approved
0.7902 Intermediate Similarity NPD943 Approved
0.7866 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7863 Intermediate Similarity NPD228 Approved
0.7853 Intermediate Similarity NPD6797 Phase 2
0.7852 Intermediate Similarity NPD6190 Approved
0.7852 Intermediate Similarity NPD9545 Approved
0.7847 Intermediate Similarity NPD447 Suspended
0.784 Intermediate Similarity NPD7054 Approved
0.7805 Intermediate Similarity NPD7251 Discontinued
0.7793 Intermediate Similarity NPD1607 Approved
0.7792 Intermediate Similarity NPD4380 Phase 2
0.7791 Intermediate Similarity NPD7074 Phase 3
0.7791 Intermediate Similarity NPD7472 Approved
0.7771 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.777 Intermediate Similarity NPD1549 Phase 2
0.7758 Intermediate Similarity NPD7808 Phase 3
0.7748 Intermediate Similarity NPD6799 Approved
0.7722 Intermediate Similarity NPD7075 Discontinued
0.7703 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7703 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD3027 Phase 3
0.7651 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7643 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7636 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7632 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7582 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.758 Intermediate Similarity NPD6801 Discontinued
0.7578 Intermediate Similarity NPD1247 Approved
0.7571 Intermediate Similarity NPD9269 Phase 2
0.7562 Intermediate Similarity NPD919 Approved
0.755 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7531 Intermediate Similarity NPD6232 Discontinued
0.7518 Intermediate Similarity NPD5536 Phase 2
0.7516 Intermediate Similarity NPD5494 Approved
0.75 Intermediate Similarity NPD824 Approved
0.75 Intermediate Similarity NPD7473 Discontinued
0.75 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD7685 Pre-registration
0.7484 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD5402 Approved
0.7452 Intermediate Similarity NPD6599 Discontinued
0.7421 Intermediate Similarity NPD1465 Phase 2
0.7412 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7405 Intermediate Similarity NPD6386 Approved
0.7405 Intermediate Similarity NPD6385 Approved
0.74 Intermediate Similarity NPD2796 Approved
0.74 Intermediate Similarity NPD2935 Discontinued
0.7384 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD3926 Phase 2
0.7372 Intermediate Similarity NPD5403 Approved
0.7368 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD5401 Approved
0.7353 Intermediate Similarity NPD1241 Discontinued
0.7351 Intermediate Similarity NPD2344 Approved
0.7349 Intermediate Similarity NPD2163 Approved
0.7305 Intermediate Similarity NPD5844 Phase 1
0.7305 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD1613 Approved
0.7297 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7286 Intermediate Similarity NPD9268 Approved
0.7246 Intermediate Similarity NPD3751 Discontinued
0.7244 Intermediate Similarity NPD3146 Approved
0.7244 Intermediate Similarity NPD2532 Approved
0.7244 Intermediate Similarity NPD3688 Clinical (unspecified phase)
0.7244 Intermediate Similarity NPD2533 Approved
0.7244 Intermediate Similarity NPD2534 Approved
0.7205 Intermediate Similarity NPD7819 Suspended
0.7203 Intermediate Similarity NPD3972 Approved
0.7203 Intermediate Similarity NPD9717 Approved
0.7203 Intermediate Similarity NPD1608 Approved
0.7194 Intermediate Similarity NPD9493 Approved
0.7171 Intermediate Similarity NPD1551 Phase 2
0.717 Intermediate Similarity NPD3455 Phase 2
0.7164 Intermediate Similarity NPD9265 Clinical (unspecified phase)
0.7163 Intermediate Similarity NPD1357 Approved
0.7161 Intermediate Similarity NPD2354 Approved
0.7161 Intermediate Similarity NPD2309 Approved
0.716 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD5353 Approved
0.7134 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7124 Intermediate Similarity NPD7266 Discontinued
0.7123 Intermediate Similarity NPD5647 Approved
0.7107 Intermediate Similarity NPD1653 Approved
0.7105 Intermediate Similarity NPD2799 Discontinued
0.7102 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD7411 Suspended
0.7076 Intermediate Similarity NPD6559 Discontinued
0.7071 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7069 Intermediate Similarity NPD8434 Phase 2
0.7063 Intermediate Similarity NPD3226 Approved
0.7055 Intermediate Similarity NPD1470 Approved
0.7055 Intermediate Similarity NPD1203 Approved
0.7051 Intermediate Similarity NPD3887 Approved
0.7047 Intermediate Similarity NPD6798 Discontinued
0.7047 Intermediate Similarity NPD411 Approved
0.7047 Intermediate Similarity NPD3764 Approved
0.7037 Intermediate Similarity NPD37 Approved
0.7032 Intermediate Similarity NPD2800 Approved
0.703 Intermediate Similarity NPD6234 Discontinued
0.7027 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.702 Intermediate Similarity NPD1933 Approved
0.702 Intermediate Similarity NPD6355 Discontinued
0.7013 Intermediate Similarity NPD1471 Phase 3
0.7007 Intermediate Similarity NPD2798 Approved
0.7006 Intermediate Similarity NPD3787 Discontinued
0.7 Intermediate Similarity NPD4062 Phase 3
0.7 Intermediate Similarity NPD6233 Phase 2
0.6994 Remote Similarity NPD1006 Clinical (unspecified phase)
0.6993 Remote Similarity NPD17 Approved
0.6993 Remote Similarity NPD1509 Clinical (unspecified phase)
0.6987 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6987 Remote Similarity NPD4110 Phase 3
0.6987 Remote Similarity NPD3750 Approved
0.6987 Remote Similarity NPD8166 Discontinued
0.6986 Remote Similarity NPD1876 Approved
0.6978 Remote Similarity NPD5283 Phase 1
0.6977 Remote Similarity NPD7038 Approved
0.6977 Remote Similarity NPD7039 Approved
0.6974 Remote Similarity NPD6651 Approved
0.6964 Remote Similarity NPD5242 Approved
0.6962 Remote Similarity NPD4357 Discontinued
0.6959 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6957 Remote Similarity NPD7458 Discontinued
0.6954 Remote Similarity NPD1558 Phase 1
0.6954 Remote Similarity NPD3620 Phase 2
0.6954 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6948 Remote Similarity NPD9570 Approved
0.6946 Remote Similarity NPD6959 Discontinued
0.6937 Remote Similarity NPD920 Approved
0.6933 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6933 Remote Similarity NPD2313 Discontinued
0.6918 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6912 Remote Similarity NPD1358 Approved
0.6909 Remote Similarity NPD4967 Phase 2
0.6909 Remote Similarity NPD4966 Approved
0.6909 Remote Similarity NPD4965 Approved
0.6903 Remote Similarity NPD2346 Discontinued
0.6903 Remote Similarity NPD2355 Clinical (unspecified phase)
0.6903 Remote Similarity NPD2353 Approved
0.6897 Remote Similarity NPD3705 Approved
0.6897 Remote Similarity NPD1201 Approved
0.6883 Remote Similarity NPD7033 Discontinued
0.6875 Remote Similarity NPD1778 Approved
0.6875 Remote Similarity NPD8150 Discontinued
0.6871 Remote Similarity NPD1283 Approved
0.6871 Remote Similarity NPD958 Approved
0.6867 Remote Similarity NPD3749 Approved
0.6864 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6861 Remote Similarity NPD2684 Approved
0.6852 Remote Similarity NPD2651 Approved
0.6852 Remote Similarity NPD2649 Approved
0.6848 Remote Similarity NPD5978 Approved
0.6848 Remote Similarity NPD5977 Approved
0.6845 Remote Similarity NPD7199 Phase 2
0.6845 Remote Similarity NPD8127 Discontinued
0.6842 Remote Similarity NPD3140 Approved
0.6842 Remote Similarity NPD7228 Approved
0.6842 Remote Similarity NPD4060 Phase 1
0.6842 Remote Similarity NPD3142 Approved
0.6831 Remote Similarity NPD6777 Approved
0.6831 Remote Similarity NPD6781 Approved
0.6831 Remote Similarity NPD6778 Approved
0.6831 Remote Similarity NPD6782 Approved
0.6831 Remote Similarity NPD6776 Approved
0.6831 Remote Similarity NPD6780 Approved
0.6831 Remote Similarity NPD6779 Approved
0.6829 Remote Similarity NPD6844 Discontinued
0.6824 Remote Similarity NPD4575 Clinical (unspecified phase)
0.6824 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6815 Remote Similarity NPD1237 Approved
0.6815 Remote Similarity NPD3060 Approved
0.6815 Remote Similarity NPD2654 Approved
0.6815 Remote Similarity NPD1243 Approved
0.6813 Remote Similarity NPD4662 Approved
0.6813 Remote Similarity NPD4661 Approved
0.6813 Remote Similarity NPD642 Clinical (unspecified phase)
0.6809 Remote Similarity NPD690 Clinical (unspecified phase)
0.6807 Remote Similarity NPD7768 Phase 2
0.6806 Remote Similarity NPD1651 Approved
0.68 Remote Similarity NPD8312 Approved
0.68 Remote Similarity NPD3534 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data